Whalerock Point Partners, LLC Novartis Ag Transaction History

Whalerock Point Partners, LLC

$404 Million
Q3 2024

A detailed history of Whalerock Point Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 2,361 shares of NVS stock, worth $246,205. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,361

Previous 2,361 -0.0%

Holding current value

$246,205

Previous $251,000 7.97%

% of portfolio

0.07%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $6,572 - $7,623	71 Added 3.1%	2,361 $251,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $9,527 - $10,847	-100 Reduced 4.18%	2,290 $221,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $180,564 - $221,122	2,390 New	2,390 $216,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $190,483 - $210,630	2,390 New	2,390 $209,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $195,454 - $227,384	-2,390 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $160,199 - $193,770	2,052 Added 607.1%	2,390 $226,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $291,761 - $323,232	-3,552 Reduced 91.31%	338 $29,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $1,696 - $2,376	-24 Reduced 0.61%	3,890 $321,000
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $2,024 - $2,288	24 Added 0.62%	3,914 $371,000
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $96,409 - $110,272	1,280 Added 49.04%	3,890 $374,000
Q2 2018 Mar 04, 2019	SELL	$64.91 - $73.36 $83,084 - $93,900	-1,280 Reduced 32.9%	2,610 $197,000
Q3 2017 Oct 31, 2017	BUY	$74.14 - $77.27 $288,404 - $300,580	3,890	3,890 $334,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Account

Whalerock Point Partners, LLC Novartis Ag Transaction History